Nuvectis Pharma, Inc.
Ticker: NVCT
| Insider | Title |
|---|---|
| Enrique Poradosu | Chief Science Business Off |
| James F Iii Oliviero | Director |
| Kenneth Hoberman | Director |
| Marlio Charles Mosseri | 10% or greater ownership |
| Matthew L. Kaplan | Director |
| Michael J. Carson | Vice President, Finance |
| Ron Bentsur | Chairman CEO, Director, 10% or greater ownership |
| Shay Shemesh | Chief Dev. Ops. Officer |
| Uri Ben-or | Int. Principal Financial Off. |